P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY

Bibliographic Details
Main Authors: P. Strati, L. Leslie, P. Shiraz, E. Budde, O. O. Oluwole, M. Ulrickson, A. Ramakrishnan, J. Sun, R. Shen, J. Kanska, P. McCroskery, J. Dong, M. Schupp, H. Xu, K. Patel
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000847652.95364.b3